Stay Up to Date
Featured News
FDA APPROVES OGSIVEO™ (NIROGACESTAT), AS THE FIRST MEDICAL THERAPY FOR THE TREATMENT OF ADULTS WITH PROGRESSING DESMOID TUMORS.
Filter by:
September 30, 2022
Desmoid Tumor Awareness Month 2022 Comes To A Close
Read More about Desmoid Tumor Awareness Month 2022 Comes To A Close
September 27, 2022
DTRF Hosts Successful 2022 Virtual DTRF “Together We Will” Weekend
Read More about DTRF Hosts Successful 2022 Virtual DTRF “Together We Will” Weekend
Clinical Trials September 13, 2022
*Big News*: Exciting Results Announced For Two Promising Desmoid Tumor Clinical Trials At ESMO Conference In France
July 21, 2022
CTOS Names “Desmoid Fibromatosis” The 2022 “Sarcoma Of The Year” For Fall Conference
Read More about CTOS Names “Desmoid Fibromatosis” The 2022 “Sarcoma Of The Year” For Fall Conference
June 6, 2022
Registration Is Open For The 2022 Virtual DTRF “Together We Will” Weekend!
Read More about Registration Is Open For The 2022 Virtual DTRF “Together We Will” Weekend!
Clinical Trials May 25, 2022
